Raymond Bergan

Professor

  • 4023 Citations
  • 37 h-Index
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

Graff, J. N., Beer, T. M., Alumkal, J. J., Slottke, R. E., Redmond, W. L., Thomas, G. V., Thompson, R. F., Wood, M. A., Koguchi, Y., Chen, Y., Latour, E., Bergan, R. C., Drake, C. G. & Moran, A. E., Jul 2 2020, In : Journal for immunotherapy of cancer. 8, 2, e00642.

Research output: Contribution to journalArticle

Open Access
2019

Genistein treatment duration effects biomarkers of cell motility in human prostate

Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 2019, In : PloS one. 14, 3, e0214078.

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells

Li, Y., Guo, Y., Feng, Z., Bergan, R., Li, B., Qin, Y., Zhao, L., Zhang, Z. & Shi, M., Aug 18 2019, In : Nutrition and Cancer. 71, 6, p. 1007-1018 12 p.

Research output: Contribution to journalArticle

7 Scopus citations

Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential (ESP) Charges

Mishra, R. K., Deibler, K. K., Clutter, M. R., Vagadia, P. P., O'Connor, M., Schiltz, G. E., Bergan, R. & Scheidt, K. A., Jan 1 2019, (Accepted/In press) In : Journal of Chemical Information and Modeling.

Research output: Contribution to journalArticle

1 Scopus citations

Rapid fabrication of vascularized and innervated cell-laden bone models with biomimetic intrafibrillar collagen mineralization

Thrivikraman, G., Athirasala, A., Gordon, R., Zhang, L., Bergan, R., Keene, D. R., Jones, J. M., Xie, H., Chen, Z., Tao, J., Wingender, B., Gower, L., Ferracane, J. L. & Bertassoni, L. E., Dec 1 2019, In : Nature communications. 10, 1, 3520.

Research output: Contribution to journalArticle

Open Access
10 Scopus citations

Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors

Deibler, K. K., Schiltz, G. E., Clutter, M. R., Mishra, R. K., Vagadia, P. P., O'Connor, M., George, M. D., Gordon, R., Fowler, G., Bergan, R. & Scheidt, K. A., Mar 22 2019, In : ChemMedChem. 14, 6, p. 615-620 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Whole-body imaging of cell death provides a systemic, minimally invasive, dynamic, and near-real time indicator for chemotherapeutic drug toxicity

Johnson, S. E., Ugolkov, A., Haney, C. R., Bondarenko, G., Li, L., Waters, E. A., Bergan, R., Tran, A., O'Halloran, T. V., Mazar, A. & Zhao, M., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1331-1342 12 p.

Research output: Contribution to journalArticle

3 Scopus citations
2018

DNA repair gene alterations and PARP inhibitor response in patients with metastatic castration-resistant prostate cancer

Lu, E., Thomas, G. V., Chen, Y., Wyatt, A. W., Lloyd, P., Youngren, J., Quigley, D., Bergan, R., Bailey, S., Beer, T. M., Feng, F. Y., Small, E. J. & Alumkal, J. J., Aug 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 8, p. 933-937 5 p.

Research output: Contribution to journalArticle

3 Scopus citations
7 Scopus citations

Precision therapeutic targeting of human cancer cell motility

Xu, L., Gordon, R., Farmer, R., Pattanayak, A., Binkowski, A., Huang, X., Avram, M., Krishna, S., Voll, E., Pavese, J., Chavez, J., Bruce, J., Mazar, A., Nibbs, A., Anderson, W., Li, L., Jovanovic, B., Pruell, S., Valsecchi, M., Francia, G. & 3 others, Betori, R., Scheidt, K. & Bergan, R., Dec 1 2018, In : Nature communications. 9, 1, 2454.

Research output: Contribution to journalArticle

11 Scopus citations

Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial

Wali, R. K., Bianchi, L., Kupfer, S., De La Cruz, M., Jovanovic, B., Weber, C., Goldberg, M. J., Rodriguez, L. M., Bergan, R., Rubin, D., Tull, M. B., Richmond, E., Parker, B., Khan, S. & Roy, H. K., Apr 2018, In : PloS one. 13, 4, e0193544.

Research output: Contribution to journalArticle

1 Scopus citations

The Role of Cruciferous Vegetables and Isothiocyanates for Lung Cancer Prevention: Current Status, Challenges, and Future Research Directions

Zhang, Z., Bergan, R., Shannon, J., Slatore, C. G., Bobe, G. & Takata, Y., Sep 2018, In : Molecular Nutrition and Food Research. 62, 18, 1700936.

Research output: Contribution to journalReview article

5 Scopus citations
2017

A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase Family

Deibler, K. K., Mishra, R. K., Clutter, M. R., Antanasijevic, A., Bergan, R., Caffrey, M. & Scheidt, K. A., May 19 2017, In : ACS chemical biology. 12, 5, p. 1245-1256 12 p.

Research output: Contribution to journalArticle

6 Scopus citations

A way forward for cancer chemoprevention: Think local

Rabadi, L. A. & Bergan, R., Jan 1 2017, In : Cancer Prevention Research. 10, 1, p. 14-35 22 p.

Research output: Contribution to journalReview article

11 Scopus citations

Selenomethionine and methyl selenocysteine: Multiple-dose pharmacokinetics in selenium-replete men

Marshall, J. R., Burk, R. F., Ondracek, R. P., Hill, K. E., Perloff, M., Davis, W., Pili, R., George, S. & Bergan, R., 2017, In : Oncotarget. 8, 16, p. 26312-26322 11 p.

Research output: Contribution to journalArticle

10 Scopus citations

Spectral biomarkers for chemoprevention of colonic neoplasia: A placebo-controlled double-blinded trial with aspirin

Roy, H. K., Turzhitsky, V., Wali, R., Radosevich, A. J., Jovanovic, B., Della'Zanna, G., Umar, A., Rubin, D. T., Goldberg, M. J., Bianchi, L., De La Cruz, M., Bogojevic, A., Helenowski, I. B., Rodriguez, L., Chatterton, R., Skripkauskas, S., Page, K., Weber, C. R., Huang, X., Richmond, E. & 2 others, Bergan, R. C. & Backman, V., Feb 1 2017, In : Gut. 66, 2, p. 285-292 8 p.

Research output: Contribution to journalArticle

15 Scopus citations
2016

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Graff, J. N., Alumkal, J. J., Drake, C. G., Thomas, G. V., Redmond, W. L., Farhad, M., Cetnar, J. P., Ey, F. S., Bergan, R. C., Slottke, R. & Beer, T. M., Aug 1 2016, In : Oncotarget. 7, 33, p. 52810-52817 8 p.

Research output: Contribution to journalArticle

180 Scopus citations
2015

Blood Telomere Length Attrition and Cancer Development in the Normative Aging Study Cohort

Hou, L., Joyce, B. T., Gao, T., Liu, L., Zheng, Y., Penedo, F. J., Liu, S., Zhang, W., Bergan, R., Dai, Q., Vokonas, P., Hoxha, M., Schwartz, J. & Baccarelli, A., Jun 1 2015, In : EBioMedicine. 2, 6, p. 591-596 6 p.

Research output: Contribution to journalArticle

41 Scopus citations

Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis

Xiao, X., Liu, Z., Wang, R., Wang, J., Zhang, S., Cai, X., Wu, K., Bergan, R. C., Xu, L. & Fan, D., 2015, In : Oncotarget. 6, 5, p. 3225-3239 15 p.

Research output: Contribution to journalArticle

Open Access
33 Scopus citations
2014

A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in Situ of the breast

Lee, O., Page, K., Ivancic, D., Helenowski, I., Parini, V., Sullivan, M. E., Margenthaler, J. A., Chatterton, R. T., Jovanovic, B., Dunn, B. K., Heckman-Stoddard, B. M., Foster, K., Muzzio, M., Shklovskaya, J., Skripkauskas, S., Kulesza, P., Green, D., Hansen, N. M., Bethke, K. P., Jeruss, J. S. & 2 others, Bergan, R. & Khan, S. A., Jul 15 2014, In : Clinical Cancer Research. 20, 14, p. 3672-3682 11 p.

Research output: Contribution to journalArticle

28 Scopus citations

Circulating giant macrophages as a potential biomarker of solid tumors

Adams, D. L., Martin, S. S., Alpaugh, R. K., Charpentier, M., Tsai, S., Bergan, R. C., Ogden, I. M., Catalona, W., Chumsri, S., Tang, C. M. & Cristofanilli, M., Mar 4 2014, In : Proceedings of the National Academy of Sciences of the United States of America. 111, 9, p. 3514-3519 6 p.

Research output: Contribution to journalArticle

95 Scopus citations

Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy

Pavese, J. M. & Bergan, R. C., Oct 1 2014, In : Cancer Letters. 352, 2, p. 179-186 8 p.

Research output: Contribution to journalArticle

26 Scopus citations

Diminished expression of h2-calponin in prostate cancer cells promotes cell proliferation, migration and the dependence of cell adhesion on substrate stiffness

Moazzem Hossain, M., Wang, X., Bergan, R. C. & Jin, J. P., 2014, In : FEBS Open Bio. 4, p. 627-636 10 p.

Research output: Contribution to journalArticle

17 Scopus citations

Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis

Pavese, J. M., Krishna, S. N. & Bergan, R. C., Jul 1 2014, In : American Journal of Clinical Nutrition. 100, SUPPL. 1, p. 431S-436S

Research output: Contribution to journalArticle

54 Scopus citations

Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression

Voll, E. A., Ogden, I. M., Pavese, J. M., Huang, X. K., Xu, L., Jovanovic, B. D. & Bergan, R. C., 2014, In : Oncotarget. 5, 9, p. 2648-2663 16 p.

Research output: Contribution to journalArticle

Open Access
30 Scopus citations

Improving diversity in cancer research trials: The story of the cancer disparities research network

Simon, M. A., De La Riva, E. E., Bergan, R., Norbeck, C., McKoy, J. M., Kulesza, P., Dong, X. Q., Schink, J. & Fleisher, L., Jun 2014, In : Journal of Cancer Education. 29, 2, p. 366-374 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis

Pavese, J. M., Ogden, I. M., Voll, E. A., Huang, X., Xu, L., Jovanovic, B. & Bergan, R. C., Jul 14 2014, In : PloS one. 9, 7, e102289.

Research output: Contribution to journalArticle

23 Scopus citations

Therapeutic modulation of prostate cancer metastasis

Krishna, S. N. & Bergan, R. C., Feb 1 2014, In : Future Medicinal Chemistry. 6, 2, p. 223-239 17 p.

Research output: Contribution to journalReview article

6 Scopus citations
2013

A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4

Krishna, S. N., Luan, C. H., Mishra, R. K., Xu, L., Scheidt, K. A., Anderson, W. F. & Bergan, R. C., Dec 5 2013, In : PloS one. 8, 12, e81504.

Research output: Contribution to journalArticle

24 Scopus citations

Androgen receptor-independent function of FoxA1 in prostate cancer metastasis

Jin, H. J., Zhao, J. C., Ogden, I., Bergan, R. C. & Yu, J., Jun 15 2013, In : Cancer Research. 73, 12, p. 3725-3736 12 p.

Research output: Contribution to journalArticle

79 Scopus citations

An orthotopic murine model of human prostate cancer metastasis.

Pavese, J., Ogden, I. M. & Bergan, R. C., 2013, In : Journal of visualized experiments : JoVE. 79, p. e50873

Research output: Contribution to journalArticle

18 Scopus citations

A phase i trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia

Wong, S. J., Campbell, B., Massey, B., Lynch, D. P., Cohen, E. E. W., Blair, E., Selle, R., Shklovskaya, J., Jovanovic, B. D., Skripkauskas, S., Dew, A., Kulesza, P., Parimi, V., Bergan, R. C. & Szabo, E., Sep 2013, In : Oral Oncology. 49, 9, p. 970-976 7 p.

Research output: Contribution to journalArticle

14 Scopus citations

Crystal structure of a type II dehydroquinate dehydratase-like protein from Bifidobacterium longum

Light, S. H., Krishna, S. N., Bergan, R. C., Lavie, A. & Anderson, W. F., Mar 2013, In : Journal of Structural and Functional Genomics. 14, 1, p. 25-30 6 p.

Research output: Contribution to journalArticle

Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors

Breen, M. J., Moran, D. M., Liu, W., Huang, X., Vary, C. P. H. & Bergan, R. C., Aug 13 2013, In : PloS one. 8, 8, e72407.

Research output: Contribution to journalArticle

15 Scopus citations

Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial

Dew, A., Khan, S., Babinski, C., Michel, N., Heffernan, M., Stephan, S., Jordan, N., Jovanovic, B., Carney, P. & Bergan, R., Apr 1 2013, In : Clinical Trials. 10, 2, p. 292-299 8 p.

Research output: Contribution to journalArticle

11 Scopus citations
2012

Soy isoflavones for breast cancer risk reduction - Response

Khan, S. A., Chatterton, R. T. & Bergan, R., Jul 1 2012, In : Cancer Prevention Research. 5, 7, p. 986-987 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Soy isoflavone supplementation for breast cancer risk reduction: A randomized phase ii trial

Khan, S. A., Chatterton, R. T., Michel, N., Bryk, M., Lee, O., Ivancic, D., Heinz, R., Zalles, C. M., Helenowski, I. B., Jovanovic, B. D., Franke, A. A., Bosland, M. C., Wang, J., Hansen, N. M., Bethke, K. P., Dew, A., Coomes, M. & Bergan, R. C., Feb 2012, In : Cancer Prevention Research. 5, 2, p. 309-319 11 p.

Research output: Contribution to journalArticle

101 Scopus citations
2011

Endoglin regulates cancer-stromal cell interactions in prostate tumors

Romero, D., O'Neill, C., Terzic, A., Contois, L., Young, K., Conley, B. A., Bergan, R. C., Brooks, P. C. & Vary, C. P. H., May 15 2011, In : Cancer Research. 71, 10, p. 3482-3493 12 p.

Research output: Contribution to journalArticle

38 Scopus citations

Endoglin suppresses human prostate cancer metastasis

Lakshman, M., Huang, X., Ananthanarayanan, V., Jovanovic, B., Liu, Y., Craft, C. S., Romero, D., Vary, C. P. H. & Bergan, R. C., Jan 1 2011, In : Clinical and Experimental Metastasis. 28, 1, p. 39-53 15 p.

Research output: Contribution to journalArticle

31 Scopus citations

Erratum: Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression (ACS Medicinal Chemistry Letters (2010) 1 (400-405) DOI: 10.1021/ml100110x)

Farmer, R. L., Biddle, M. M., Nibbs, A. E., Huang, X., Xu, L., Bergan, R. C. & Scheidt, K. A., Mar 10 2011, In : ACS Medicinal Chemistry Letters. 2, 3, p. 257 1 p.

Research output: Contribution to journalComment/debate

Methyl selenocysteine: Single-dose pharmacokinetics in men

Marshall, J. R., Ip, C., Romano, K., Fetterly, G., Fakih, M., Jovanovic, B., Perloff, M., Crowell, J., Davis, W., French-Christy, R., Dew, A., Coomes, M. & Bergan, R., Nov 2011, In : Cancer Prevention Research. 4, 11, p. 1938-1944 7 p.

Research output: Contribution to journalArticle

23 Scopus citations

The Ninth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research

Xu, L., Wang, S. S., Healey, M. A., Faupel-Badger, J. M., Wilken, J. A., Battaglia, T., Szabo, E., Mao, J. T. & Bergan, R. C., Apr 2011, In : Cancer Prevention Research. 4, 4, p. 616-621 6 p.

Research output: Contribution to journalArticle

2 Scopus citations
2010

Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression

Farmer, R. L., Biddle, M. M., Nibbs, A. E., Huang, X., Bergan, R. C. & Scheidt, K. A., Nov 11 2010, In : ACS Medicinal Chemistry Letters. 1, 8, p. 400-405 6 p.

Research output: Contribution to journalArticle

31 Scopus citations

Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration

Romero, D., Terzic, A., Conley, B. A., Craft, C. S., Jovanovic, B., Bergan, R. C. & Vary, C. P. H., Mar 2010, In : Carcinogenesis. 31, 3, p. 359-366 8 p.

Research output: Contribution to journalArticle

23 Scopus citations

Inhibition of cancer cell invasion and metastasis by genistein

Pavese, J. M., Farmer, R. L. & Bergan, R. C., Sep 2010, In : Cancer and Metastasis Reviews. 29, 3, p. 465-482 18 p.

Research output: Contribution to journalReview article

151 Scopus citations
2009

Labeling TiO2 nanoparticles with dyes for optical fluorescence microscopy and determination of TiO2-DNA nanoconjugate stability

Thurn, K. T., Paunesku, T., Wu, A., Brown, E. M. B., Lai, B., Vogt, S., Maser, J., Aslam, M., Dravid, V., Bergan, R. & Woloschak, G. E., Jun 5 2009, In : Small. 5, 11, p. 1318-1325 8 p.

Research output: Contribution to journalArticle

72 Scopus citations

MEK4 function, genistein treatment, and invasion of human prostate cancer cells

Xu, L., Ding, Y., Catalona, W. J., Yang, X. J., Anderson, W. F., Jovanovic, B., Wellman, K., Killmer, J., Huang, X., Scheidt, K. A., Montgomery, R. B. & Bergan, R. C., Aug 2009, In : Journal of the National Cancer Institute. 101, 16, p. 1141-1155 15 p.

Research output: Contribution to journalArticle

68 Scopus citations
2008

Dietary genistein inhibits metastasis of human prostate cancer in mice

Lakshman, M., Xu, L., Ananthanarayanan, V., Cooper, J., Takimoto, C. H., Helenowski, I., Pelling, J. C. & Bergan, R. C., Mar 15 2008, In : Cancer Research. 68, 6, p. 2024-2032 9 p.

Research output: Contribution to journalArticle

126 Scopus citations

Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images

Paunesku, T., Ke, T., Dharmakumar, R., Mascheri, N., Wu, A., Lai, B., Vogt, S., Maser, J., Thurn, K., Szolc-Kowalska, B., Larson, A., Bergan, R. C., Omary, R., Li, D., Lu, Z. R. & Woloschak, G. E., Sep 2008, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 4, 3, p. 201-207 7 p.

Research output: Contribution to journalArticle

39 Scopus citations

Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells

Craft, C. S., Xu, L., Romero, D., Vary, C. P. H. & Bergan, R. C., Jan 2008, In : Molecular pharmacology. 73, 1, p. 235-242 8 p.

Research output: Contribution to journalArticle

25 Scopus citations